The AACR remains fully committed to supporting publishing operations throughout this challenging time, while still remaining flexible and supportive of the author, reviewer, and editor communities that we serve. If you have any questions or concerns, please reach out to a member of the AACR publishing staff.
Please visit the COVID-19 & Cancer Resource Center where COVID-related content is freely available.
Trending - Altmetric
- Hallmarks of RET and Co-occuring Genomic Alterations in RET-aberrant CancersLast mentioned on Wed Nov 24 2021
- Enhanced anti-tumor responses of tumor antigen-specific TCR-T cells genetically engineered to produce IL-7 and CCL19Last mentioned on Tue Nov 16 2021
- Clinical Next-Generation Sequencing for Precision Oncology in Rare CancersLast mentioned on Mon Nov 08 2021
- Exploitation of sulfated glycosaminoglycan status for precision medicine of Triplatin in triple-negative breast cancerLast mentioned on Tue Nov 30 2021
- See more
Advertisement
